- Home
- NVO vs HSBC Comparison
NVO vs HSBC Comparison
Compare NVO & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- HSBC
- Stock Information
- Founded
- NVO 1923
- HSBC 1865
- Country
- NVO Denmark
- HSBC United Kingdom
- Employees
- NVO N/A
- HSBC N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- HSBC Savings Institutions
- Sector
- NVO Health Care
- HSBC Finance
- Exchange
- NVO Nasdaq
- HSBC Nasdaq
- Market Cap
- NVO 278.0B
- HSBC 226.5B
- IPO Year
- NVO N/A
- HSBC N/A
- Fundamental
- Price
- NVO $56.32
- HSBC $65.22
- Analyst Decision
- NVO Buy
- HSBC Buy
- Analyst Count
- NVO 7
- HSBC 1
- Target Price
- NVO $98.00
- HSBC N/A
- AVG Volume (30 Days)
- NVO 30.0M
- HSBC 1.4M
- Earning Date
- NVO 08-06-2025
- HSBC 07-30-2025
- Dividend Yield
- NVO 2.19%
- HSBC 5.03%
- EPS Growth
- NVO 24.25
- HSBC N/A
- EPS
- NVO 3.93
- HSBC 1.00
- Revenue
- NVO $49,108,936,497.00
- HSBC $56,208,000,000.00
- Revenue This Year
- NVO $13.92
- HSBC $10.40
- Revenue Next Year
- NVO $14.04
- HSBC $1.08
- P/E Ratio
- NVO $14.34
- HSBC $65.40
- Revenue Growth
- NVO 20.91
- HSBC N/A
- 52 Week Low
- NVO $45.05
- HSBC $42.38
- 52 Week High
- NVO $139.74
- HSBC $66.05
- Technical
- Relative Strength Index (RSI)
- NVO 50.25
- HSBC 59.17
- Support Level
- NVO $53.83
- HSBC $63.51
- Resistance Level
- NVO $55.48
- HSBC $66.05
- Average True Range (ATR)
- NVO 1.20
- HSBC 0.61
- MACD
- NVO 1.39
- HSBC 0.07
- Stochastic Oscillator
- NVO 84.80
- HSBC 77.07
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.